BBIOBridgeBio Pharma, Inc.

$74.76

What is the market doing?

What the tape says about BBIO

BridgeBio Pharma, Inc. is +53% over the past year while the S&P 500 is +20%: 32 points ahead of the market.

+53%

1-year return · S&P 500 +20%

vs 200-day average
+2.5%

vs 200-day average · close to trend

RSI (14)
31

RSI (14) · neutral

Below its 52-week high
13%

Below its 52-week high

2024-08-15$22.35 – $85.86 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$74.76
1 monthS&P 500 −0.30%
−9.7%
1 yearS&P 500 +20%
+53%
5 yearsS&P 500 +85%
+43%
vs 50-day average$78.04
−4.2%
52-week high
$85.86
52-week low
$47.29
Annualised volatility
53%
Calendar-year price return
YearReturn
2026 (year to date)−2.3%
2025+179%
2024−32%
2023+430%
2022−54%
2021−77%
2020+103%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan73 of 7−4.3%
Feb73 of 7+0.96%
Mar73 of 7+7.8%
Apr72 of 7−6.8%
May72 of 7−3.8%
Jun76 of 7+13%
Jul85 of 8+15%
Aug85 of 8+2.1%
Sep82 of 8−4.8%
Oct75 of 7+4.2%
Nov75 of 7+10%
Dec75 of 7+4.7%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.